Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease: Volume 20-2

CHF 122.75
Auf Lager
SKU
FVK2PLBSA6H
Stock 1 Verfügbar
Geliefert zwischen Mi., 25.02.2026 und Do., 26.02.2026

Details

Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to end stage liver disease with resultant cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, several extrahepatic conditions may be linked to NAFLD including cardiovascular disease, insulin requiring and type 2 diabetes mellitus, obstructive sleep apnea, colonic adenomas, hyperuricemia, vitamin D deficiency, hyperferritinemia, pancreatic steatosis, hypothyroidism, and polycystic ovarian syndrome. Therapies for NAFLD are evolving rapidly. This issue will analyze patient demographics, risk factors, pathophysiology, patient presentation, and treatments for NAFLD.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09780323416962
    • Sprache Englisch
    • Größe H229mm x B152mm
    • Jahr 2016
    • EAN 9780323416962
    • Format Fester Einband
    • ISBN 978-0-323-41696-2
    • Veröffentlichung 20.04.2016
    • Titel Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease: Volume 20-2
    • Autor Gaglio Paul J.
    • Gewicht 520g
    • Herausgeber Elsevier Health Science
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38